Focusing on long noncoding RNA dysregulation in gastric cancer

Tumor Biology

Volumn 36, Issue 1, 2015, Pages 129-141

  Gan, Lu ^a,b   Xu, Midie ^a,b   Zhang, Yi ^c   Zhang, Xia ^d   Guo, Weijian ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c The 452nd Hospital of PLA   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Dysregulation; Function; Gastric cancer; Long noncoding RNAs

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; GELATINASE B; GLUCOCORTICOID RECEPTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HOX PROTEIN; LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; PROTEIN P53; PROTEINASE ACTIVATED RECEPTOR 1; RNA H19; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

APOPTOSIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN; CHROMOSOME; DISEASE FREE SURVIVAL; DNA BINDING; DNA DAMAGE; EARLY DIAGNOSIS; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GAS5 GENE; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; H19 GENE; HISTONE MODIFICATION; LIVER CANCER; MATERNALLY EXPRESSED GENE 3; ONCOGENE C MYC; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECONDARY STRUCTURE; REGULATORY MECHANISM; REVIEW; RNA SPLICING; RNA TRANSLATION; STOMACH CANCER; SYSTEMATIC REVIEW; TUMOR DIAGNOSIS; ANIMAL; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PROGNOSIS; STOMACH TUMOR;

ANIMALS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROGNOSIS; RNA, LONG NONCODING; STOMACH NEOPLASMS;

EID: 84925541437     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2894-9     Document Type: Review

References (137)

1. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489:101–8.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921.
3. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding rnas. Cell. 2009;136:629–41.
4. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microrna-related disease? Transl Res J Lab Clin Med. 2011;157:253–64.
5. Lindsay MA. Micrornas and the immune response. Trends Immunol. 2008;29:343–51.
6. Ling H, Fabbri M, Calin GA. Micrornas and other non-coding rnas as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12:847–65.
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. Microrna expression profiles classify human cancers. Nature. 2005;435:834–8.
8. Nana-Sinkam SP, Croce CM. Clinical applications for micrornas in cancer. Clin Pharmacol Ther. 2013;93:98–104.
9. O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for micrornas in the immune system. Nat Rev Immunol. 2010;10:111–22.
10. O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. C-myc-regulated micrornas modulate e2f1 expression. Nature. 2005;435:839–43.
11. Rottiers V, Naar AM. Micrornas in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239–50.
12. Tian W, Chen J, He H, Deng Y. Micrornas and drug resistance of breast cancer: Basic evidence and clinical applications. Clin Transl Oncol Off Publ Fed Spanish Oncol Soc Nat Cancer Inst Mexico. 2013;15:335–42.
13. Xia JT, Chen LZ, Jian WH, Wang KB, Yang YZ, He WL, et al. Microrna-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of nf-kappab signaling. J Transl Med. 2014;12:33.
14. Chen Q, Ge X, Zhang Y, Xia H, Yuan D, Tang Q, et al. Plasma mir-122 and mir-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Oncol Rep. 2014;31:1863–70.
15. Ma L, Bajic VB, Zhang Z. On the classification of long non-coding rnas. RNA Biol. 2013;10:925–33.
16. Brown CJ, Hendrich BD, Rupert JL, Lafreniere RG, Xing Y, Lawrence J, et al. The human xist gene: Analysis of a 17 kb inactive x-specific rna that contains conserved repeats and is highly localized within the nucleus. Cell. 1992;71:527–42.
17. Mattick JS. Makunin IV: Non-coding rna. Hum Mol Genet. 2006;15(Spec No 1):R17–29.
18. Guttman M, Rinn JL. Modular regulatory principles of large non-coding rnas. Nature. 2012;482:339–46.
19. Batista PJ, Chang HY. Long noncoding rnas: cellular address codes in development and disease. Cell. 2013;152:1298–307.
20. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465:182–7.
21. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al. Chromatin signature reveals over a thousand highly conserved large non-coding rnas in mammals. Nature. 2009;458:223–7.
22. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding rna in human carcinomas. Mol Cancer. 2011;10:38.
23. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding rnas and cancer: a new frontier of translational research? Oncogene. 2012;31:4577–87.
24. Clark MB, Mattick JS. Long noncoding rnas in cell biology. Semin Cell Dev Biol. 2011;22:366–76.
25. Mercer TR, Qureshi IA, Gokhan S, Dinger ME, Li G, Mattick JS, et al. Long noncoding rnas in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci. 2010;11:14.
26. Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, et al. Control of somatic tissue differentiation by the long non-coding rna tincr. Nature. 2013;493:231–5.
27. Fatica A, Bozzoni I. Long non-coding rnas: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7–21.
28. Harries LW. Long non-coding rnas and human disease. Biochem Soc Trans. 2012;40:902–6.
29. Maruyama R, Suzuki H. Long noncoding rna involvement in cancer. BMB Rep. 2012;45:604–11.
30. Wang KC, Chang HY. Molecular mechanisms of long noncoding rnas. Mol Cell. 2011;43:904–14.
31. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human hox loci by noncoding rnas. Cell. 2007;129:1311–23.
32. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding rna maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472:120–4.
33. Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A, et al. Long noncoding rna hottip/hoxa13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2014;59:911–23.
34. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding rna induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142:409–19.
35. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, et al. Extensive and coordinated transcription of noncoding rnas within cell-cycle promoters. Nat Genet. 2011;43:621–9.
36. Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. Noncoding rna gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3:ra8.
37. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, Feil R, et al. The air noncoding rna epigenetically silences transcription by targeting g9a to chromatin. Science. 2008;322:1717–20.
38. Heo JB, Sung S. Vernalization-mediated epigenetic silencing by a long intronic noncoding rna. Science. 2011;331:76–9.
39. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding rna hotair reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6.
40. He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, et al. Long noncoding rnas: novel insights into hepatocelluar carcinoma. Cancer Lett. 2014;344:20–7.
41. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding rna as modular scaffold of histone modification complexes. Science. 2010;329:689–93.
42. Gil J, Peters G. Regulation of the ink4b-arf-ink4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol. 2006;7:667–77.
43. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the noncoding rna anril and methylated histone h3 lysine 27 by polycomb cbx7 in transcriptional silencing of ink4a. Mol Cell. 2010;38:662–74.
44. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, et al. Long non-coding rna anril is required for the prc2 recruitment to and silencing of p15(ink4b) tumor suppressor gene. Oncogene. 2011;30:1956–62.
45. Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N, et al. Large noncoding rna hotair enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem Biophys Res Commun. 2013;436:319–24.
46. Tang L, Zhang W, Su B, Yu B. Long noncoding rna hotair is associated with motility, invasion, and metastatic potential of metastatic melanoma. BioMed Res Int. 2013;2013:251098.
47. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, et al. Long noncoding rna hotair regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71:6320–6.
48. Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H, et al. Upregulation of mir-196a and hotair drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012;72:1126–36.
49. Hajjari M, Behmanesh M, Sadeghizadeh M, Zeinoddini M. Up-regulation of hotair long non-coding rna in human gastric adenocarcinoma tissues. Med Oncol. 2013;30:670.
50. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, et al. Hotair is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013;32:1616–25.
51. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, et al. Overexpression of long non-coding rna hotair predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol. 2011;18:1243–50.
52. Maass PG, Luft FC, Bahring S. Long non-coding rna in health and disease. J Mol Med. 2014;92:337–46.
53. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477–90.
54. Ilson DH. Angiogenesis in gastric cancer: hitting the target? Lancet. 2014;383:4–6.
55. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:2137–50.
56. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, et al. Up-regulated long non-coding rna h19 contributes to proliferation of gastric cancer cells. FEBS J. 2012;279:3159–65.
57. Bartolomei MS, Zemel S, Tilghman SM. Parental imprinting of the mouse h19 gene. Nature. 1991;351:153–5.
58. Gabory A, Jammes H, Dandolo L. The h19 locus: role of an imprinted non-coding rna in growth and development. BioEssays News Rev Mol Cell Dev Biol. 2010;32:473–80.
59. Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ, Huang L, et al. Knockdown of long non-coding rna hotair suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci. 2013;9:587–97.
60. Lee NK, Lee JH, Park CH, Yu D, Lee YC, Cheong JH, et al. Long non-coding rna hotair promotes carcinogenesis and invasion of gastric adenocarcinoma. Biochem Biophys Res Commun. 2014;451:171–8.
61. Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, et al. Lnc rna hotair functions as a competing endogenous rna to regulate her2 expression by sponging mir-331-3p in gastric cancer. Mol Cancer. 2014;13:92.
62. Zhang EB, Han L, Yin DD, Kong R, De W, Chen J. C-myc-induced, long, noncoding h19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol. 2014;31:914.
63. Li H, Yu B, Li J, Su L, Yan M, Zhu Z, et al. Overexpression of lncrna h19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014;5:2318–29.
64. Zhuang M, Gao W, Xu J, Wang P, Shu Y. The long non-coding rna h19-derived mir-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor runx1. Biochem Biophys Res Commun. 2014;448:315–22.
65. Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L, et al. Long noncoding rna anril indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of mir-99a/mir-449a. Oncotarget. 2014;5:2276–92.
66. Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin L, et al. Decreased expression of the long non-coding rna fendrr is associated with poor prognosis in gastric cancer and fendrr regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol. 2014;7:63.
67. Zhao Y, Guo Q, Chen J, Hu J, Wang S, Sun Y. Role of long non-coding rna hulc in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep. 2014;31:358–64.
68. Sun M, Xia R, Jin F, Xu T, Liu Z, De W, et al. Downregulated long noncoding rna meg3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:1065–73.
69. Yan J, Guo X, Xia J, Shan T, Gu C, Liang Z, et al. Mir-148a regulates meg3 in gastric cancer by targeting DNA methyltransferase 1. Med Oncol. 2014;31:879.
70. Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y, et al. Long noncoding rna ccat1, which could be activated by c-myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol. 2013;139:437–45.
71. Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi K, et al. Long non-coding rna ghet1 promotes gastric carcinoma cell proliferation by increasing c-myc mrna stability. FEBS J. 2014;281:802–13.
72. Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T, et al. Decreased expression of long noncoding rna ac096655.1–002 in gastric cancer and its clinical significance. Tumour Biol J Int Soc Oncodev Biol Med. 2013;34:2697–701.
73. Xiao B, Guo J. Long noncoding rna ac096655.1–002 has been officially named as gastric cancer-associated transcript 1, gacat1. Tumour Biol J Int Soc Oncodev Biol Med. 2013;34:3271.
74. Shao Y, Chen H, Jiang X, Chen S, Li P, Ye M. et al. Low expression of lncrna-hmlincrna717 in human gastric cancer and its clinical significances. Tumour Biol J Int Soc Oncodev Biol Med. 2014.
75. Xu C, Shao Y, Xia T, Yang Y, Dai J, Luo L. et al. Lncrna-ac130710 targeting by mir-129-5p is upregulated in gastric cancer and associates with poor prognosis. Tumour Biol J Int Soc Oncodev Biol Med. 2014.
76. Park SM, Park SJ, Kim HJ, Kwon OH, Kang TW, Sohn HA, et al. A known expressed sequence tag, bm742401, is a potent lincrna inhibiting cancer metastasis. Exp Mol Med. 2013;45:e31.
77. Liu Z, Shao Y, Tan L, Shi H, Chen S, Guo J. Clinical significance of the low expression of fer1l4 in gastric cancer patients. Tumour Biol J Int Soc Oncodev Biol Med. 2014.
78. Chen X, Sun J, Song Y, Gao P, Zhao J, Huang X, et al. The novel long noncoding rna ac138128.1 may be a predictive biomarker in gastric cancer. Med Oncol. 2014;31:262.
79. Liu L, Yan B, Yang Z, Zhang X, Gu Q, Yue X. Ncrupar inhibits gastric cancer progression by down-regulating protease-activated receptor-1. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:7821–9.
80. Mei D, Song H, Wang K, Lou Y, Sun W, Liu Z, et al. Up-regulation of sumo1 pseudogene 3 (sumo1p3) in gastric cancer and its clinical association. Med Oncol. 2013;30:709.
81. Lin X, Yang M, Xia T, Guo J. Increased expression of long noncoding rna abhd11-as1 in gastric cancer and its clinical significance. Med Oncol. 2014;31:42.
82. Hu Y, Wang J, Qian J, Kong X, Tang J, Wang Y. et al. Long non-coding rna gaplinc regulates cd44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer Res. 2014.
83. Wang Y, Zhang D, Wu K, Zhao Q, Nie Y, Fan D. Long noncoding rna mrul promotes abcb1 expression in multidrug-resistant gastric cancer cell sublines. Mol Cell Biol. 2014;34:3182–93.
84. Ding J, Li D, Gong M, Wang J, Huang X, Wu T, et al. Expression and clinical significance of the long non-coding rna pvt1 in human gastric cancer. OncoTargets Ther. 2014;7:1625–30.
85. Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, et al. Gastric juice long noncoding rna used as a tumor marker for screening gastric cancer. Cancer. 2014;120:3320–8.
86. Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, et al. Increased expression of long intergenic non-coding rna linc00152 in gastric cancer and its clinical significance. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:5441–7.
87. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor ii gene. Cell. 1991;64:849–59.
88. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, et al. The imprinted h19 lncrna antagonizes let-7 micrornas. Mol Cell. 2013;52:101–12.
89. Cooper WN, Luharia A, Evans GA, Raza H, Haire AC, Grundy R, et al. Molecular subtypes and phenotypic expression of beckwith-wiedemann syndrome. Eur J Human Genet EJHG. 2005;13:1025–32.
90. Weksberg R, Smith AC, Squire J, Sadowski P. Beckwith-wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet. 2003;12(Spec No 1):R61–8.
91. Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, et al. The h19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A. 2008;105:12417–22.
92. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, et al. The h19 non-coding rna is essential for human tumor growth. PLoS One. 2007;2:e845.
93. Woo CJ, Kingston RE. Hotair lifts noncoding rnas to new levels. Cell. 2007;129:1257–9.
94. Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, et al. Clinical significance of the expression of long non-coding rna hotair in primary hepatocellular carcinoma. Oncol Rep. 2013;29:946–50.
95. Liu XH, Liu ZL, Sun M, Liu J, Wang ZX, De W. The long non-coding rna hotair indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer. 2013;13:464.
96. Nie Y, Liu X, Qu S, Song E, Zou H, Gong C. Long non-coding rna hotair is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci. 2013;104:458–64.
97. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding rna malat1 regulates alternative splicing by modulating sr splicing factor phosphorylation. Mol Cell. 2010;39:925–38.
98. Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K. et al. Metastasis-associated long non-coding rna drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis 2014.
99. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology. 2006;44:1012–24.
100. Schmidt LH, Spieker T, Koschmieder S, Schaffers S, Humberg J, Jungen D, et al. The long noncoding malat-1 rna indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol Off Publ Int Assoc Stud Lung Cancer. 2011;6:1984–92.
101. Shen L, Chen L, Wang Y, Jiang X, Xia H, Zhuang Z. Long noncoding rna malat1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. J Neuro-Oncol. 2014.
102. Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z, et al. Long non-coding rna malat1 promotes tumour growth and metastasis in colorectal cancer through binding to sfpq and releasing oncogene ptbp2 from sfpq/ptbp2 complex. Br J Cancer. 2014;111:736–48.
103. Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding Q, et al. Malat1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the erk/mapk pathway. Cancer Biol Ther. 2014;15:806–14.
104. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding rna malat1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73:1180–9.
105. Zhao Z, Chen C, Liu Y, Wu C. 17beta-estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing malat-1 rna level. Biochem Biophys Res Commun. 2014;445:388–93.
106. Liu SP, Yang JX, Cao DY, Shen K. Identification of differentially expressed long non-coding rnas in human ovarian cancer cells with different metastatic potentials. Cancer Biolo Med. 2013;10:138–41.
107. Wang J, Su L, Chen X, Li P, Cai Q, Yu B. et al. Malat1 promotes cell proliferation in gastric cancer by recruiting sf2/asf. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2014;68:557–564.
108. Yin D, He X, Zhang E, Kong R, De W, Zhang Z. Long noncoding rna gas5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31:253.
109. Tu ZQ, Li RJ, Mei JZ, Li XH. Down-regulation of long non-coding rna gas5 is associated with the prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol. 2014;7:4303–9.
110. Pickard MR, Williams GT. Regulation of apoptosis by long non-coding rna gas5 in breast cancer cells: Implications for chemotherapy. Breast Cancer Res Treat. 2014;145:359–70.
111. Liu Z, Wang W, Jiang J, Bao E, Xu D, Zeng Y, et al. Downregulation of gas5 promotes bladder cancer cell proliferation, partly by regulating cdk6. PLoS One. 2013;8:e73991.
112. Qiao HP, Gao WS, Huo JX, Yang ZS. Long non-coding rna gas5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prevent APJCP. 2013;14:1077–82.
113. Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP, et al. Decreased expression of long noncoding rna gas5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14:319.
114. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of hulc, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding rna. Gastroenterology. 2007;132:330–42.
115. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. Creb up-regulates long non-coding rna, hulc expression through interaction with microrna-372 in liver cancer. Nucleic Acids Res. 2010;38:5366–83.
116. Hammerle M, Gutschner T, Uckelmann H, Ozgur S, Fiskin E, Gross M, et al. Posttranscriptional destabilization of the liver-specific long noncoding rna hulc by the igf2 mrna-binding protein 1 (igf2bp1). Hepatology. 2013;58:1703–12.
117. Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, Aisaka K, et al. Identification of an imprinted gene, meg3/gtl2 and its human homologue meg3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells Devoted Mol Cell Mech. 2000;5:211–20.
118. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, et al. A pituitary-derived meg3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88:5119–26.
119. Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, et al. Loss of imprinting and allelic switching at the dlk1-meg3 locus in human hepatocellular carcinoma. PLoS One. 2012;7:e49462.
120. Balik V, Srovnal J, Sulla I, Kalita O, Foltanova T, Vaverka M, et al. Meg3: a novel long noncoding potentially tumour-suppressing rna in meningiomas. J Neuro-Oncol. 2013;112:1–8.
121. Benetatos L, Vartholomatos G, Hatzimichael E. Meg3 imprinted gene contribution in tumorigenesis. Int J Cancer J Int Cancer. 2011;129:773–9.
122. Wang P, Ren Z, Sun P. Overexpression of the long non-coding rna meg3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113:1868–74.
123. Zhou Y, Zhang X, Klibanski A. Meg3 noncoding rna: a tumor suppressor. J Mol Endocrinol. 2012;48:R45–53.
124. Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ, et al. Long non-coding rna meg3 inhibits nsclc cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461.
125. Nissan A, Stojadinovic A, Mitrani-Rosenbaum S, Halle D, Grinbaum R, Roistacher M, et al. Colon cancer associated transcript-1: a novel rna expressed in malignant and pre-malignant human tissues. Int J Cancer J Int Cancer. 2012;130:1598–606.
126. Alaiyan B, Ilyayev N, Stojadinovic A, Izadjoo M, Roistacher M, Pavlov V, et al. Differential expression of colon cancer associated transcript1 (ccat1) along the colonic adenoma-carcinoma sequence. BMC Cancer. 2013;13:196.
127. He X, Tan X, Wang X, Jin H, Liu L, Ma L. et al. C-myc-activated long noncoding rna ccat1 promotes colon cancer cell proliferation and invasion. Tumour Biol J Int Soc Oncodevelopmental Biol Med 2014.
128. Chen S, Li P, Xiao B, Guo J. Long noncoding rna hmlincrna717 and ac130710 have been officially named as gastric cancer associated transcript 2 (gacat2) and gacat3, respectively. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:8351–2.
129. Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi Y, et al. Long noncoding rna associated-competing endogenous rnas in gastric cancer. Sci Rep. 2014;4:6088.
130. Doventas A, Bilici A, Demirell F, Ersoy G, Turna H, Doventas Y. Prognostic significance of cd44 and c-erb-b2 protein overexpression in patients with gastric cancer. Hepato-Gastroenterology. 2012;59:2196–201.
131. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426–37.
132. Graham LD, Pedersen SK, Brown GS, Ho T, Kassir Z, Moynihan AT, et al. Colorectal neoplasia differentially expressed (crnde), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes Cancer. 2011;2:829–40.
133. Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M, et al. Characterization of human plasma-derived exosomal rnas by deep sequencing. BMC Genomics. 2013;14:319.
134. Xie H, Ma H, Zhou D. Plasma hulc as a promising novel biomarker for the detection of hepatocellular carcinoma. BioMed Res Int. 2013;2013:136106.
135. Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, et al. Circulating long non-coding rnas in plasma of patients with gastric cancer. Anticancer Res. 2013;33:3185–93.
136. Xu MD, Qi P, Du X. Long non-coding rnas in colorectal cancer: Implications for pathogenesis and clinical application. Modern Pathol Off J USA Can Acad Pathol Inc. 2014;27:1310–20.
137. Burnett JC, Rossi JJ. Rna-based therapeutics: current progress and future prospects. Chem Biol. 2012;19:60–71.